Flow Cytometry Market to Surpass US$ 12,532.8 Million by 2030, Says Coherent Market Insights (CMI)

Burlingame, Feb. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global flow cytometry market is estimated to be valued at US$ 5,688.7 in 2022 and is expected to exhibit a CAGR of 10.4% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Flow Cytometry Market:

Adoption of inorganic growth strategies such as product approval by key market players is expected to drive the global flow cytometry market over the forecast period. For instance, in September 2020, Cytek Biosciences, a manufacturer of flow cytometry products, announced that they had received CE mark approval for Cytek Northern Lights flow cytometer, which is available for clinical diagnostic use in hospitals, laboratories and clinics across Europe, by offering a complete spectral flow cytometry solution to the European market from instruments to reagents.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1152

Flow Cytometry Market Report Coverage

Key Market Takeaways:

The global flow cytometry market is expected to exhibit a CAGR of 10.4% during the forecast period due to the increasing inorganic strategies such as acquisition by the key market players. For instance, in November 2021, Cytek Biosciences, a manufacturer of flow cytometry products, announced that they had acquired Tonbo Biosciences’ Cell Analysis Business which includes an extensive portfolio of life science research reagents related to cell preparation, flow cytometry, and cell culture covering application areas across immunology, apoptosis, and immunoprofiling. This acquisition will enable Cytek Biosciences to offer extended flow cytometry capabilities to meet customer needs in protein and cell analysis research.

Among product type, analyzer is expected to boost the market due to increasing product launch by key market players over the forecast period. For instance, in August 2021, BD, a medical technology company, announced that they had launched FACSymphony A1 cell analyzer to enhance lab research. FACSymphony A1 cell analyzer that enables the precise isolation of selected single cells from complex samples.

Competitive Landscape:

Key players operating in the global flow cytometry market include General Electric, BD, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., Laboratory Corporation of America Holdings., and MilliporeSigma

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1152

Market Segmentation:

• Global Flow Cytometry Market, By Technology:
  • Cell Based
  • Bead Based
• Global Flow Cytometry Market, By Product Type:
  • Analyzer
  • Sorter
  • Reagent & Consumables
• Global Flow Cytometry Market, By Application:
  • Research
  • Clinical
  • Industrial
• Global Flow Cytometry Market, By End User:
  • Hospitals
  • Clinical Testing Laboratories
  • Research Laboratories
• Global Flow Cytometry Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Reports:

Immuno-Oncology Assays Market, By Product (Consumables and Software), By Technology (Immunoassay, PCR, NGS, Flow Cytometry, and Others), By Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, and Others), By Application (Clinical Diagnostics and Research and Development), and By Region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028

Research Antibodies Market, by Product Type (Primary Antibodies, Secondary Antibodies, Reagents, Consumables), by Form (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Mouse, Rabbit, Goat, Others (Guinea Pigs, Rat, etc.)), by Application (Western Blotting, ELISA, Flow Cytometry, Immunocytochemistry (ICC)/ Immunofluorescence (IF), Immunohistochemistry (IHC), Others), by End User (Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedIn | Twitter